Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| N-Pharma | Pharma | 27.2% | 70th pct | 110 |
| Zion Development | Pharma | 20.7% | 60th pct | 110 |
| Eco Resurs Nattek | Pharma | 17.6% | 54th pct | 110 |
| Kava Pharma | Pharma | 4.6% | 22nd pct | 110 |
| Piluet Georgia | Pharma | -6.3% | 6th pct | 110 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
| Line item | Kava Pharma | Zion Development | N-Pharma | Piluet Georgia | Eco Resurs Nattek |
|---|---|---|---|---|---|
| Total Current Assets | 2,597 | 2,659 | 4,388 | 1,102 | 2,828 |
| Total Non-Current Assets | 2,121 | 95 | 1,215 | 332 | 933 |
| TOTAL ASSETS | 4,718 | 2,754 | 5,603 | 1,434 | 3,761 |
| Total Current Liabilities | 2,805 | 14 | 1,530 | 1,091 | 298 |
| Total Non-Current Liabilities | 86 | 0 | 43 | 1,893 | 1,041 |
| TOTAL LIABILITIES | 2,890 | 14 | 1,574 | 2,983 | 1,339 |
| Total Equity | 1,828 | 2,739 | 4,030 | -1,549 | 2,421 |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 |
| Total Debt | 1,534 | 0 | 1,341 | 1,962 | 1,064 |
| Cash & Equivalents | 104 | 2,265 | 916 | 215 | 661 |
| Net Debt | 1,430 | -2,265 | 426 | 1,747 | 403 |